Mitigating Benzodiazepine Dependence and the Risk of Drug-Induced QTc Prolongation in the Treatment of Gastroparesis: A Case Report

Mitigating Benzodiazepine Dependence and the Risk of Drug-Induced QTc Prolongation in the Treatment of Gastroparesis: A Case Report

Patients are often faced with challenges when it comes to safe therapeutic options. An 89-year-old female with a history of arrhythmias and refractory gastroparesis complained of adverse drug events from her benzodiazepine. While performing a comprehensive medication review and a medication safety r...

Full description

Bibliographic Details
Main Authors:	Karley Tranchina, Derek Matlock, Carlos Hernandez, Jacques Turgeon, Jennifer M. Bingham
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Medicina
Subjects:	benzodiazepine dependence QTc prolongation pharmacist medication safety gastroparesis
Online Access:	https://www.mdpi.com/1648-9144/58/3/409

Similar Items

Developing a Model for Quantifying QTc-Prolongation Risk to Enhance Medication Safety Assessment: A Retrospective Analysis
by: Luis Giovannoni, et al.
Published: (2024-01-01)

QTc Intervals Are Prolonged in Late Preterm and Term Neonates during Therapeutic Hypothermia but Normalize Afterwards
by: Karel Allegaert, et al.
Published: (2021-12-01)

QTc Interval Prolongation and Stroke: Any Differences between Ischemic and Hemorrhagic Strokes?
by: Osama Shukir Muhammed Amin, et al.
Published: (2014-02-01)

Determinants of severe QTc prolongation in a real-world gerontopsychiatric setting
by: Martin Schulze Westhoff, et al.
Published: (2023-03-01)

A Comparison of QTc Abnormalities in Cirrhotics with Non-Cirrohotic
by: M Mujtaba Ali, et al.
Published: (2020-12-01)

Assessment of Prescribing and Monitoring Habits for Patients Taking an Antiarrhythmic and Concomitant QTc-Prolonging Antibiotic
by: Kelsey Noss, et al.
Published: (2017-11-01)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
by: Arwa Younis, et al.
Published: (2022-06-01)

Comparison of Antipsychotics for the Treatment of Patients With Delirium and QTc Interval Prolongation: A Clinical Decision Analysis
by: Ken Kurisu, et al.
Published: (2021-06-01)

The Prevalence, Risk Factors and Clinical Correlates of QTc Prolongation in Chinese Hospitalized Patients With Chronic Schizophrenia
by: Haiyan Cao, et al.
Published: (2021-08-01)

Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose
by: Borje Darpo, et al.
Published: (2023-02-01)

Hydroxychloroquine and QTc: beyond COVID-19
by: Alberto Castagna, et al.
Published: (2020-10-01)

Prevalence of QT prolongation and its risk factors in patients with type 2 diabetes
by: Khaled Aburisheh, et al.
Published: (2023-03-01)

A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient
by: Shmeylan Al Harbi, et al.
Published: (2022-01-01)

Effect of serum electrolytes within normal ranges on QTc prolongation: a cross-sectional study in a Chinese rural general population
by: Yintao Chen, et al.
Published: (2018-08-01)

Association between a frailty index based on common laboratory tests and QTc prolongation in older adults: the Rugao Longevity and Ageing Study
by: Ma T, et al.
Published: (2018-04-01)

Does Azithromycin and Cetirizine Combination Given for Upper Respiratory Tract Infections has any Significant Effect on QTc?
by: Kishor Kumar Rajasekaran, et al.
Published: (2017-09-01)

QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review
by: Torres-Yaghi Y, et al.
Published: (2021-12-01)

QTc Aralığı Uzaması ve İnme: İskemik ve Hemorajik İnme Arasındaki Farklar
by: Osama Shukir Muhammed AMİN, et al.
Published: (2014-07-01)

QTc prolongation during the SARS-CoV-2 outbreak: clinical risk management through hospital training course, focus on elderly patients
by: Nicola Forni, et al.
Published: (2020-08-01)

Elevated Interleukin‐6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans
by: Pietro Enea Lazzerini, et al.
Published: (2024-02-01)

QTc interval prolongation in the patients with primary biliary cholangitis
by: Zihao Wang, et al.
Published: (2022-01-01)

HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers
by: Sujeet Jha, et al.
Published: (2021-01-01)

Prevalence of QTc Prolongation in Patients with Parkinson’s Disease. Assessment of the Effects of Drugs, Clinical Risk Factors and Used Correction Formula
by: Jakub J. Malkiewicz, et al.
Published: (2021-03-01)

The association of QTc prolongation with cardiovascular events in cancer patients taking tyrosine kinase inhibitors (TKIs)
by: Ismail Ghafary, et al.
Published: (2023-05-01)

The role of pharmacists in deprescribing benzodiazepines: A scoping review
by: Fatemah Zakariya Ashkanani, et al.
Published: (2023-12-01)

PROLONGED DISPERSION OF QT AND QTC IN THALASSEMIA MAJOR PATIENTS
by: A. Kocharian, et al.
Published: (2003-08-01)

Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population
by: Jennifer M. Bingham, et al.
Published: (2020-02-01)

Evaluation of QTc interval in Iranian causalities (Janbazan) of Iran-Iraq war receiving maintenance methadone treatment
by: Morteza Abdar Esfahani, et al.
Published: (2012-01-01)

Assessment of Drug-Induced QTc Prolongation in Mental Health Practice: Validation of an Evidence-Based Algorithm
by: Zolezzi M, et al.
Published: (2023-10-01)

Diabetic gastroparesis: current challenges and future prospects
by: Avalos DJ, et al.
Published: (2018-09-01)

Mirtazapine for symptom control in refractory gastroparesis
by: Malamood M, et al.
Published: (2017-03-01)

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
by: Sarah Grewal, et al.
Published: (2020-09-01)

Reprogramming of gastric motility with "pulse therapy" (metoclopramide and erythromycin) in severe gastroparesis
by: Shamik Shah, et al.
Published: (2013-01-01)

QTc prolongation risk among patients receiving oral targeted antineoplastic medications: A real-world community-based oncology analysis
by: David J. Reeves, et al.
Published: (2023-03-01)

Suffering in Silence: Is Gastroparesis Underdiagnosed?
by: Dennis J. Baumgardner
Published: (2019-04-01)

Dynamics of the QTc interval over a 24‐h dose interval after start of intravenous ciprofloxacin or low‐dose erythromycin administration in ICU patients
by: Florine A. Berger, et al.
Published: (2021-12-01)

QT interval prolongation noted in one percent of 2553 Asian patients with schizophrenia: Findings from the REAP‐AP survey
by: Seon‐Cheol Park, et al.
Published: (2020-12-01)

THE PROPORTION OF PATIENTS WITH HYPERTENSION IN THE GROUPS OF TERMS PROLONGED QTc INTERVALS PER DAY DATA OF AMBULATORY ECG MONITORING IN DEPENDENCE FROM CLINICAL SIGNS
by: Tselik N. E., et al.
Published: (2018-07-01)

Risk of QTc Interval Prolongation Associated With Circulating Anti‐Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study
by: Pietro Enea Lazzerini, et al.
Published: (2021-02-01)

Application of acupuncture in diabetic gastroparesis: A case series
by: Jianzhi Cao, et al.
Published: (2024-03-01)